Humana's Q2 profit hits $694M as Medicare Advantage costs align with expectations

Humana reported a second-quarter net income of $694 million, driven by a surge in Medicare Advantage enrollees to 7.1 million, up from 5.8 million a year ago. Despite rising medical costs industry-wide, Humana managed to keep its benefit ratio at 91.2%, in line with management's guidance, reflecting controlled medical and pharmacy expenses. The company’s revenue rose to $40.8 billion, beating Wall Street expectations, as it capitalized on operational efficiency and clinical care improvements. CEO Jim Rechtin highlighted that the company remains on track to deliver strong earnings and better health outcomes by focusing on value-based care.